Neurological
1957, Japan — Takeuchi Kiyoshi and colleagues' early angiographic observations published in Japanese medical literature
Moyamoya disease was a cerebrovascular condition first formally characterized by Japanese physicians in the mid-twentieth century, though retrospective analysis suggested that cases consistent with the condition had likely been observed and misclassified for many decades prior. The disease was defined by a progressive narrowing of the internal carotid arteries and the development of an abnormal compensatory network of small blood vessels at the base of the brain. Its distinctive angiographic appearance gave rise to the Japanese term meaning 'puff of smoke,' which became the condition's internationally recognized name.
Historical Narrative
The formal medical history of moyamoya disease began in Japan in the 1950s, when advances in cerebral angiography allowed physicians to visualize the brain's blood vessel architecture with unprecedented clarity. In 1957, Japanese radiologist Takeuchi Kiyoshi and his colleagues published early observations of an unusual angiographic pattern in patients experiencing strokes and neurological episodes, noting the strange proliferation of small collateral vessels at the base of the brain that appeared in response to occlusion of the major feeding arteries. These findings were initially met with uncertainty, as the pattern did not conform to the established categories of cerebrovascular disease recognized in the Western medical literature of the time.
The term 'moyamoya,' drawn from a Japanese expression evoking the hazy, indistinct appearance of a puff of smoke drifting in the air, was introduced into the medical literature in 1969 by Suzuki Jiro and Takaku Akira in a foundational paper that systematically described the condition's angiographic stages. Suzuki's staging system, which characterized the progressive obliteration of the carotid arteries and the corresponding evolution of the collateral vessel network, gave researchers and clinicians a shared framework for discussing the disease and became a cornerstone of moyamoya research for subsequent decades.
Before the angiographic era, conditions that likely represented moyamoya disease were recorded in Japanese clinical literature under various descriptive labels, including 'hypoplasia of the bilateral internal carotid arteries' and 'rete mirabile' — a term borrowed from classical anatomy referring to a mesh-like vascular structure. Western physicians had occasionally encountered similar angiographic findings but had generally attributed them to atherosclerotic disease or to the sequelae of other known vascular conditions, failing to recognize moyamoya as a distinct entity.
Early investigations into the disease's etiology focused heavily on the geographic and ethnic clustering of cases, with the overwhelming preponderance of documented patients being of Japanese and East Asian ancestry. This observation prompted hypotheses involving genetic predisposition, and family aggregation studies conducted during the 1970s and 1980s provided early evidence that hereditary factors played a role. Japanese researchers including Fukuyama Yukio contributed important epidemiological work during this period, helping to establish that the condition occurred in both pediatric and adult populations and that its clinical course differed substantially between these groups.
The latter decades of the twentieth century saw moyamoya gain recognition outside Japan as improved neuroimaging technologies, including CT scanning and MRI, became widely available. Western neurologists and neurosurgeons began identifying cases that had previously gone unrecognized, and international research collaborations began to explore the condition's pathophysiology. Surgical revascularization procedures, pioneered substantially by Japanese neurosurgeons, became the subject of historical investigation as practitioners worked to understand which patients had historically benefited from attempts to restore blood flow to the affected brain tissue. The molecular genetic investigation of moyamoya deepened considerably in the early twenty-first century, with researchers identifying the RNF213 gene as a significant susceptibility locus in East Asian populations, marking a major turning point in understanding why the condition appeared with such striking geographic and ethnic patterning.
Key Historical Figures
Historical narrative only — this page describes how Moyamoya disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.